HomeALZN • NASDAQ
add
Alzamend Neuro Inc
Previous close
$0.73
Day range
$0.70 - $0.74
Year range
$0.65 - $11.90
Market cap
4.94M USD
Avg Volume
48.54K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jan 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.66M | -50.96% |
Net income | -2.66M | 50.93% |
Net profit margin | — | — |
Earnings per share | -0.38 | 57.78% |
EBITDA | -2.65M | 51.14% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jan 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 282.87K | -96.16% |
Total assets | 782.64K | -90.79% |
Total liabilities | 4.57M | 72.90% |
Total equity | -3.79M | — |
Shares outstanding | 6.87M | — |
Price to book | -1.15 | — |
Return on assets | -753.00% | — |
Return on capital | 205.60% | — |
Cash Flow
Net change in cash
(USD) | Jan 2024info | Y/Y change |
---|---|---|
Net income | -2.66M | 50.93% |
Cash from operations | -2.03M | -12.43% |
Cash from investing | 0.00 | — |
Cash from financing | 2.11M | — |
Net change in cash | 82.79K | 104.58% |
Free cash flow | -1.03M | -35.65% |
About
Founded
2016
Headquarters
Website
Employees
6